Brickell Biotech Inc BBI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/20/22 EDT
0.17quote price arrow up+0.00 (+1.23%)
Volume
29,768
Close
0.163quote price arrow down-0.0051 (-3.0339%)
Volume
8,002,504
52 week range
0.16 - 1.04
Loading...
  • Open0.1686
  • Day High0.178
  • Day Low0.16
  • Prev Close0.1681
  • 52 Week High1.04
  • 52 Week High Date06/30/21
  • 52 Week Low0.16
  • 52 Week Low Date05/19/22

Key Stats

  • Market Cap19.46M
  • Shares Out119.38M
  • 10 Day Average Volume3.41M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change-28.79

KEY STATS

  • Open0.1686
  • Day High0.178
  • Day Low0.16
  • Prev Close0.1681
  • 52 Week High1.04
  • 52 Week High Date06/30/21
  • 52 Week Low0.16
  • 52 Week Low Date05/19/22
  • Market Cap19.46M
  • Shares Out119.38M
  • 10 Day Average Volume3.41M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change-28.79

RATIOS/PROFITABILITY

  • EPS (TTM)-0.46
  • P/E (TTM)-0.36
  • Fwd P/E (NTM)-0.95
  • EBITDA (TTM)-40.621M
  • ROE (TTM)-176.49%
  • Revenue (TTM)480,000.00
  • Gross Margin (TTM)0.00%
  • Net Margin (TTM)-8,325.47%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Brickell Biotech Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Brickell Biotech, Inc. is a clinical-stage pharmaceutical company engaged in developing prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases. The Company’s pipeline combines several development-stage candidates and a cutting-edge platform with autoimmune and inflammatory disorders program for the treatment of primary axillary hyperhidrosis. Its products include Cialis, Taltz, Gemzar, Prozac, Cymbalta and Juvederm. Its lead...
Reginald Hardy
Chairman of the Board, Co-Founder
Robert Brown
Chief Executive Officer, Director
Albert Marchio II
Chief Financial Officer
Jose Breton
Chief Accounting Officer, Controller
Address
5777 Central Ave Ste 102
Boulder, CO
80301-2870
United States

Top Peers

SYMBOLLASTCHG%CHG
ONTX
Onconova Therapeutics Inc
1.09-0.03-2.55%
BPTH
Bio Path Holdings Inc
3.13-0.07-2.19%
RVPH
Reviva Pharmaceuticals Holdings, Inc.
1.75-0.04-2.23%
PBLA
Panbela Therapeutics Inc
1.45-0.05-3.33%
CANF
Can Fite Biopharma Ltd
0.90UNCHUNCH